Using CSF biomarkers to replicate genetic associations in Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 7, 2012, Pages 1486.e9-1486.e15

  Schott, Jonathan M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Genome wide association studies

Indexed keywords

APOLIPOPROTEIN E4; BIOLOGICAL MARKER; TAU PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; APOE E4 GENE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CR1 GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PICALM GENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; TOMM40 GENE;

EID: 84861182718     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.02.008     Document Type: Article

References (15)

1. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet 2007, 39:17-23.
2. Biffi A., Anderson C.D., Desikan R.S., Sabuncu M., Cortellini L., Schmansky N., Salat D., Rosand J. Genetic variation and neuroimaging measures in Alzheimer disease. Arch. Neurol 2010, 67:677-685.
3. Carrasquillo M.M., Belbin O., Hunter T.A., Ma L., Bisceglio G.D., Zou F., Crook J.E., Pankratz V.S., Dickson D.W., Graff-Radford N.R., Petersen R.C., Morgan K., Younkin S.G. Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch. Neurol 2010, 67:961-964.
4. Corneveaux J.J., Myers A.J., Allen A.N., Pruzin J.J., Ramirez M., Engel A., Nalls M.A., Chen K., Lee W., Chewning K., Villa S.E., Meechoovet H.B., Gerber J.D., Frost D., Benson H.L., O'Reilly S., Chibnik L.B., Shulman J.M., Singleton A.B., Craig D.W., Keuren-Jensen K.R., Dunckley T., Bennett D.A., De Jager P.L., Heward C., Hardy J., Reiman E.M., Huentelman M.J. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum. Mol. Genet 2010, 19:3295-3301.
5. Cruchaga C., Kauwe J.S., Mayo K., Spiegel N., Bertelsen S., Nowotny P., Shah A.R., Abraham R., Hollingworth P., Harold D., Owen M.M., Williams J., Lovestone S., Peskind E.R., Li G., Leverenz J.B., Galasko D., Morris J.C., Fagan A.M., Holtzman D.M., Goate A.M. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet. 2010, 6:e1001101.
6. De Meyer G., Shapiro F., Vanderstichele H., Vanmechelen E., Engelborghs S., De Deyn P.P., Coart E., Hansson O., Minthon L., Zetterberg H., Blennow K., Shaw L., Trojanowski J.Q. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol 2010, 67:949-956.
7. Han M.R., Schellenberg G.D., Wang L.S. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study. BMC Neurol. 2010, 10:90.
8. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., van den Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet 2009, 41:1088-1093.
9. Jun G., Naj A.C., Beecham G.W., Wang L.S., Buros J., Gallins P.J., Buxbaum J.D., Ertekin-Taner N., Fallin M.D., Friedland R., Inzelberg R., Kramer P., Rogaeva E., George-Hyslop P., Arnold S.E., Baldwin C.T., Barber R., Beach T., Bigio E.H., Bird T.D., Boxer A., Burke J.R., Cairns N., Carroll S.L., Chui H.C., Clark D.G., Cotman C.W., Cummings J.L., Decarli C., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Gearing M., Geschwind D.H., Ghetti B., Gilman S., Giordani B., Glass J., Graff-Radford N.R., Green R.C., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A., Lopez O.L., Mack W.J., Markesbery W., Marson D.C., Martiniuk F., Masliah E., McKee A.C., Mesulam M., Miller J.W., Miller B.L., Miller C.A., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W., Quinn J.F., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider J.A., Schneider L.S., Seeley W., Shelanski M.L., Smith C.D., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Woltjer R.L., Younkin S.G., Cantwell L.B., Dombroski B.A., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Lunetta K.L., Martin E.R., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Beekly D., Cupples L.A., Hakonarson H., Kukull W., Foroud T.M., Haines J., Mayeux R., Farrer L.A., Pericak-Vance M.A., Schellenberg G.D., Arnold S.E., Baldwin C.T., Barber R., Beach T., Bigio E.H., Bird T.D., Boxer A., Burke J.R., Cairns N., Carroll S.L., Chui H.C., Clark D.G., Cotman C.W., Cummings J.L., Decarli C., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Gearing M., Geschwind D.H., Ghetti B., Gilman S., Giordani B., Glass J., Graff-Radford N.R., Green R.C., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A., Lopez O.L., Mack W.J., Markesbery W., Marson D.C., Martiniuk F., Masliah E., McKee A.C., Mesulam M., Miller J.W., Miller B.L., Miller C.A., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W., Quinn J.F., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider J.A., Schneider L.S., Seeley W., Shelanski M.L., Smith C.D., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Woltjer R.L., Younkin S.G. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol 2010, 67:1473-1484.
10. Kim S., Swaminathan S., Shen L., Risacher S.L., Nho K., Foroud T., Shaw L.M., Trojanowski J.Q., Potkin S.G., Huentelman M.J., Craig D.W., Dechairo B.M., Aisen P.S., Petersen R.C., Weiner M.W., Saykin A.J. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology 2011, 76:69-79.
11. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fievet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanche H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet 2009, 41:1094-1099.
12. Saykin A.J., Shen L., Foroud T.M., Potkin S.G., Swaminathan S., Kim S., Risacher S.L., Nho K., Huentelman M.J., Craig D.W., Thompson P.M., Stein J.L., Moore J.H., Farrer L.A., Green R.C., Bertram L., Jack C.R., Weiner M.W. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement 2010, 6:265-273.
13. Schott J.M., Bartlett J.W., Fox N.C., Barnes J. Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Ann. Neurol 2010, 68:825-834.
14. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., Harold D., Schrijvers E.M., Ramirez-Lorca R., Debette S., Longstreth W.T., Janssens A.C., Pankratz V.S., Dartigues J.F., Hollingworth P., Aspelund T., Hernandez I., Beiser A., Kuller L.H., Koudstaal P.J., Dickson D.W., Tzourio C., Abraham R., Antunez C., Du Y., Rotter J.I., Aulchenko Y.S., Harris T.B., Petersen R.C., Berr C., Owen M.J., Lopez-Arrieta J., Varadarajan B.N., Becker J.T., Rivadeneira F., Nalls M.A., Graff-Radford N.R., Campion D., Auerbach S., Rice K., Hofman A., Jonsson P.V., Schmidt H., Lathrop M., Mosley T.H., Au R., Psaty B.M., Uitterlinden A.G., Farrer L.A., Lumley T., Ruiz A., Williams J., Amouyel P., Younkin S.G., Wolf P.A., Launer L.J., Lopez O.L., van Duijn C.M., Breteler M.M. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840.
15. Shaw L.M., Vanderstichele H., Knapik-Czajka M., Clark C.M., Aisen P.S., Petersen R.C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V.M., Trojanowski J.Q. Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann. Neurol 2009, 65:403-413.